Anal cancer incidence in HIV-infected patients seems to have increased after the introduction of effective ART, perhaps because HIV-infected patients are living longer.
Anal cancer is much more common among HIV-infected patients than in the general population. The incidence of most HIV-associated opportunistic conditions has dropped markedly since the introduction of combination antiretroviral therapy (ART) in 1996. If HIV-related immunosuppression were the main cause of the high anal cancer rate, one would expect tumor incidence to have fallen after the advent of effective therapy.
Investigators in France identified 132 cases of anal cancer among 86,322 HIV-infected patients who were part of a nationwide hospital-based cohort. The median age at cancer diagnosis was 43. Ninety-four percent of cases were in men; 71% were in men who have sex with men (MSM). At the time of cancer diagnosis, 78% of patients had…
Reviewing Author
DisclosuresGrant/Research SupportNIH
Editorial BoardsUpToDate; ID Images (idimages.org); Infectious Diseases Society of America COVID-19 Treatment Guidelines; International Antiviral Society–USA (Guidelines Committee)
Leadership Positions in Professional SocietiesHIV Medicine Association; Infectious Diseases Society of America (Board of Directors)
DisclosuresGrant/Research SupportNIH
Editorial BoardsUpToDate; ID Images (idimages.org); Infectious Diseases Society of America COVID-19 Treatment Guidelines; International Antiviral Society–USA (Guidelines Committee)
Leadership Positions in Professional SocietiesHIV Medicine Association; Infectious Diseases Society of America (Board of Directors)